Found 21 matching trials
An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
PHASE3This study will investigate the application of a vasopressin antagonist in ...
Location
Multiple Locations
Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure
NAThe purpose of the study is to compare the effects of conivaptan and diuret...
Location
Hennepin county Medical Center
Study of Stroke Related Edema Treatments
PHASE2Stroke remains the fourth leading cause of death in the United States (seco...
Location
Multiple Locations
Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
PHASE3The study is designed to assess the efficacy and safety of multiple infusio...
Location
Multiple Locations
Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury
PHASE1The investigators plan to utilize conivaptan (Vaprisol) to promote isolated...
Location
Harborview Medical Center
Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study
PHASE1The goal of this study is to preliminarily determine/estimate feasibility a...
Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure
PHASE2This is a randomized, double-blind, placebo-controlled, dose ranging pilot ...
Location
The Heart Center, P.C.
Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients
PHASE3Low sodium levels (hyponatremia) are a frequent occurrence in medically ill...
Location
Columbia University Medical Center
Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients
PHASE4Conivaptan (Vaprisol) is FDA-Approved for the treatment of low serum sodium...
Location
Multiple Locations
Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure
NASecondary hyperaldosteronism and the non-osmotic release of arginine vasopr...
Location
University of Colorado at Denver and Health Sciences Center General Clinical Research Center